• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Whistleblowers accuse Fla. VA hospital of ignoring Alaris recall

August 27, 2019 By Sean Whooley

Staff members at a Florida U.S. Veterans Affairs Dept. hospital reportedly said leadership ignored the recall of the Alaris infusion pump made by Becton Dickinson (NYSE:BDX).

Leaders at the James Haley Veterans’ Hospital in Tampa dismissed repeated warnings about BD’s device over multiple weeks, even after a patient’s life was endangered, the Military Times reported.

On July 18, BD updated the recalls on the Alaris pumps and infusion sets following the initial recall on April 15, when BD notified clinicians that the manufacturing process of the pumps resulted in weakened plastic. Over time, the weakened plastic could lead to free flow, over-infusion, under-infusion or interruption of the infusion. The July recall urged hospitals to destroy all affected products found in their inventories.

A patient at the Tampa facility received too much prescribed medication due to what nurses described as an IV malfunction. Hospital staff filed a grievance saying that a medical disaster was avoided only due to the quick-thinking nurses who diagnosed the problem. James Haley Veterans’ Hospital continued to use the recalled tubing for weeks after the July 31 incident despite formal complaints from the nurses’ union in early August, the newspaper reported.

Nurses who raised concerns about the recalled tubing were told IV equipment shortages were to blame, but VA officials, in response to the grievance, denied that claim and said appropriate equipment is available. All affected tubing at the facility is being replaced immediately, the hospital told the Military Times this week.

Filed Under: Featured, Hospital Care, Recalls Tagged With: Becton Dickinson

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS